SIMPLEX TRADING, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is and the CUSIP is 74587V907. A total of 3 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$5
-93.9%
2,200
-90.6%
0.00%
Q2 2023$82
-47.1%
23,300
-53.7%
0.00%
Q1 2023$155
-42.8%
50,300
-21.5%
0.00%
Q4 2022$271
-99.9%
64,100
-49.2%
0.00%
Q3 2022$299,000
+269.1%
126,300
+341.6%
0.00%
Q2 2022$81,000
+50.0%
28,600
+51.3%
0.00%
Q1 2022$54,000
-8.5%
18,900
-4.1%
0.00%
Q4 2021$59,000
-27.2%
19,700
+126.4%
0.00%
Q3 2021$81,000
+5.2%
8,700
+3.6%
0.00%
Q2 2021$77,0008,400
+3400.0%
0.00%
Q1 2021$0
-100.0%
240
-48.1%
0.00%
-100.0%
Q4 2020$474,000
+6.0%
462
+4.1%
0.00%0.0%
Q3 2020$447,000
+12.6%
444
+16.5%
0.00%0.0%
Q2 2020$397,000
+28.5%
381
+3.8%
0.00%0.0%
Q1 2020$309,000
-64.4%
367
-63.0%
0.00%
-50.0%
Q4 2019$868,000
-0.6%
993
+22.4%
0.00%0.0%
Q3 2019$873,000
+4.6%
811
+23.4%
0.00%0.0%
Q2 2019$835,000
-74.1%
657
-21.0%
0.00%
-77.8%
Q1 2019$3,227,000
+846.3%
832
+395.2%
0.01%
+800.0%
Q4 2018$341,000
-25.5%
168
+68.0%
0.00%0.0%
Q3 2018$458,000
-44.3%
100
-28.1%
0.00%
-66.7%
Q2 2018$822,000
+207.9%
139
-94.5%
0.00%
-75.0%
Q1 2018$267,000
+178.1%
2,528
+2805.7%
0.01%
+200.0%
Q4 2017$96,000
-88.7%
87
-64.5%
0.00%
-88.6%
Q3 2017$850,000
+178.7%
245
+35.4%
0.04%
+169.2%
Q2 2017$305,000
+1694.1%
181
+112.9%
0.01%
+1200.0%
Q1 2017$17,000
+1600.0%
85
+507.1%
0.00%
Q4 2016$1,000
-98.8%
14
-83.9%
0.00%
-100.0%
Q3 2016$83,000
+1560.0%
87
+480.0%
0.01%
Q2 2016$5,000
-28.6%
15
-74.6%
0.00%
-100.0%
Q1 2016$7,000
-63.2%
59
+3.5%
0.00%0.0%
Q4 2015$19,000
-13.6%
57
-68.5%
0.00%
-50.0%
Q3 2015$22,000
+57.1%
181
+132.1%
0.00%
+100.0%
Q2 2015$14,000
+16.7%
78
+1200.0%
0.00%0.0%
Q1 2015$12,000
-82.9%
6
-92.8%
0.00%
-87.5%
Q4 2014$70,000830.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 462$474,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 24,600$252,0000.00%
View complete list of PUMA BIOTECHNOLOGY INC shareholders